Date published: 2026-4-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

NS 1643 (CAS 448895-37-2)

5.0(1)
Write a reviewAsk a question

See product citations (3)

Alternate Names:
N,N′-Bis[2-hydroxy-5-(trifluoromethyl)phenyl] urea
Application:
NS 1643 is an antiarrhythmic activator of hERG K+ channels
CAS Number:
448895-37-2
Molecular Weight:
380.25
Molecular Formula:
C15H10F6N2O3
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

NS 1643 is a HERG(hERG K+ channel) activator, such as KCNH6. Displays different molecular mechanisms of action at hERG1 and hERG2 channels. Exhibits antiarrhythmic activity in vitro.


NS 1643 (CAS 448895-37-2) References

  1. Erg K+ channels modulate contractile activity in the bovine epididymal duct.  |  Mewe, M., et al. 2008. Am J Physiol Regul Integr Comp Physiol. 294: R895-904. PMID: 18184764
  2. Electrophysiologic characterization of a novel hERG channel activator.  |  Su, Z., et al. 2009. Biochem Pharmacol. 77: 1383-90. PMID: 19426677
  3. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).  |  Lu, HR., et al. 2013. J Pharmacol Toxicol Methods. 68: 250-259. PMID: 23337247
  4. hERG1/Kv11.1 activation stimulates transcription of p21waf/cip in breast cancer cells via a calcineurin-dependent mechanism.  |  Perez-Neut, M., et al. 2016. Oncotarget. 7: 58893-58902. PMID: 25945833
  5. Activation of hERG3 channel stimulates autophagy and promotes cellular senescence in melanoma.  |  Perez-Neut, M., et al. 2016. Oncotarget. 7: 21991-2004. PMID: 26942884
  6. Pharmacological rescue of hERG currents carried out by G604S and wide type hERG co-expression.  |  Huo, J., et al. 2016. Clin Exp Pharmacol Physiol. 43: 851-61. PMID: 27199074
  7. Human Engineered Heart Tissue: Analysis of Contractile Force.  |  Mannhardt, I., et al. 2016. Stem Cell Reports. 7: 29-42. PMID: 27211213
  8. CSAHi study-2: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes: Assessment of reference compounds and comparison with non-clinical studies and clinical information.  |  Nozaki, Y., et al. 2017. Regul Toxicol Pharmacol. 88: 238-251. PMID: 28634147
  9. NS1643 enhances ionic currents in a G604S-WT hERG co-expression system associated with long QT syndrome 2.  |  Huo, J., et al. 2017. Clin Exp Pharmacol Physiol. 44: 1125-1133. PMID: 28741726
  10. ERG3 potassium channel-mediated suppression of neuronal intrinsic excitability and prevention of seizure generation in mice.  |  Xiao, K., et al. 2018. J Physiol. 596: 4729-4752. PMID: 30016551
  11. Utility of the JT Peak Interval and the JT Area in Determining the Proarrhythmic Potential of QT-Shortening Agents.  |  Qiu, B., et al. 2019. J Cardiovasc Pharmacol Ther. 24: 160-171. PMID: 30092655
  12. Electrophysiological Profile Remodeling via Selective Suppression of Voltage-Gated Currents by CLN1/PPT1 Overexpression in Human Neuronal-Like Cells.  |  Demontis, GC., et al. 2020. Front Cell Neurosci. 14: 569598. PMID: 33390903

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

NS 1643, 10 mg

sc-204135
10 mg
$123.00

NS 1643, 50 mg

sc-204135A
50 mg
$473.00